Amarin Corp Plc (AMRN)

[CJR_MS]

HDG & O

The Bristol Myers - Celgene acquisition contained a CVR for three CELG drugs.

Ticker for the CVR is BMYRT - currently trading at $3.97 with a potential payout of $9 should all 3 drugs get approval. When it initially began to trade it was around $2/CVR.

If we get a CVR it will be tradeable as HD said and value will be determined by the market.

I am firmly in the BO + CVR camp if no settlement is imminently available. The decision should be made in the next 30-60 days based on EU timeline. If the company partners for EU/RoW I will be shocked.

What a lesson in greed this has been (for many of us). File it away for yours future benefit.

All the best,
Cam